PM

Peter Mcbride

Senior Business Development Advisor at Second Heart Assist Inc.

Peter McBride is an accomplished healthcare professional with extensive experience in cardiovascular medicine and business development. Currently serving as the Executive Director of Cardiovascular Medicine at Imago Systems, Inc., Peter also holds positions as a Healthcare Business Analyst at GE Healthcare USA and as a Business Analyst and Advisory Board Member at Leonhardt Ventures | Cal-X Stars Business Accelerator Inc. Peter founded and serves as the CEO of Cardiovascular Resources Solutions, Inc., and is actively involved in education as a faculty member for Loma Linda University’s Electrophysiology Program. In addition, Peter contributes to Medi+Sphere Development, Inc. as the Director of Technology and Education, oversees Cardiovascular Business Development as an Executive Consultant with Charles Franc & Associates, Inc. and SpringBoard Healthcare, and has held various leadership roles in cardiovascular services across multiple healthcare institutions. Peter holds a Bachelor's Degree in Finance from the University of Phoenix and an Associate's Degree in Cardiovascular Medicine from Grossmont College.

Location

Fallbrook, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Second Heart Assist Inc.

Second Heart is developing a minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The platform will be deployed using low-profile catheter-based techniques and will provide either temporary or chronic circulatory support, depending on the specific needs of the patient. Second Heart's initialproduct will be a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing high-risk percutaneous coronary intervention (PCI). The second application will be a wirelessly powered circulatory assist pump that will provide chronic circulatory support for heart failure patients.